1Dhein S,Zhao Y,Simsek S,et al.Actions of dihydropyridines in isolated mesenteric vascular beds[].Journal of Cardiovascular Pharmacology.1995
2Navarro-Cid J,Maeso R,Rodrigo E,et al.Renal and vascular consequences of the chronic nitric oxide synthase inhibition:effects of antihypertensive drugs[].American Journal of Hypertension.1996
3Anderson TJ.Assessment and treatment of endothelial dysfunction in humans[].Journal of the American College of Cardiology.1999
4Hishikawa K,Nakai T,Marumo T,et al.Pressure enhances endothelin-l release from cultured human endothelial cells[].Journal of Hypertension.1995
5Michelson AD,Benoit SE,Furman MI,et al.Effects of endothelium-derived relaxing factor nitric oxide on platelet surface glycoproteins[].American Journal of Physiology.1996
6Zhang X,Hintze TH.Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of calcium channel -blocking agent[].Circulation.1998
7Dhein S,Salameh A,Berkels R,et al.Duel mode of action of dihydropyridine calcium antagonists: a role for nitric oxide[].Drugs.1999
8Diodati JG,Dakak N,Gilligan DM,et al.Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans[].Circulation.1998
9Ishii K,Chang B,Kerwin JF,et al.N-Nitro-L-Arginine: a potent inhibitor of endothelium-derived relaxing factor formation[].European Journal of Pharmacology.1990
10Salameh A,Schomecker G,Breitopf K,et al.The effect of the calcium-antagonist nitrendipine on intracellular calcium concentration in endothelial cells[].British Journal of Pharmacology.1996
